The CAPREG Score: Is it accurate to predict cardiac complications in women with severe valve disease? - 06/01/20
Résumé |
Background |
Adequate prepregnancy prediction of maternal cardiovascular risk is important for counselling and management of pregnancy in women with sever heart valve disease (SHVD)
Patients and methods |
In this retrospective study, we determined the outcomes of 60 pregnancies in 54 women with SHVD. The CARPREG (CARdiac disease in PREGnancy) risk scores were calculated for each pregnancy, as was the total number of cardiovascular (TPc) risk predictors (TPo) from these and other studies combined.
Results |
Maternal cardiovascular events occurred during 37 pregnancies (61%).
Cardiovascular event rates increased with higher risk scores. The predictors of cardiac events were severe mitral stenosis, revelation of the heart disease by pregnancy, systolic pulmonary arterial pressure and the parity. The area under the curve (AUC) of CARPREG risk score for maternal cardiovascular risk was 0.69 (P=0.32). The threshold value of 2 was predictive of cardiac maternal complications, corresponding to a sensitivity of 60% and a specificity of 66%.
Conclusion |
The CARPREG risk score is accurate to predict cardiac complications in our population of pregnant patients with severe valve heart disease.
Le texte complet de cet article est disponible en PDF.Plan
Vol 12 - N° 1
P. 43 - janvier 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.

